Business
Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
VANCOUVER, BC / ACCESS Newswire / February 4, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has filed a preliminary base shelf prospectus dated February 3, 2026 (the ...

About this update from Onco-innovations Ltd.
[{"type":"text","content":"VANCOUVER, BC / ACCESS Newswire / February 4, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has filed a preliminary base shelf prospectus dated February 3, 2026 (the "Base Shelf Prospectus") with the securities regulatory authorities in each of the provinces of Alberta, British Columbia, Manitoba and Ontario. The Base Shelf Prospectus has been filed, but is not yet final, and the securities described therein may not be sold until (i) a receipt for a final short form base shelf prospectus is obtained from the applicable securities regulatory authorities, and (ii) a prospectus supplement containing a description of any particular securities offering is filed with the applicable securities regulatory authorities.","length":834,"tagName":"p"},{"type":"text","content":"The Base Shelf Prospectus, once final and a receipt is obtained, is intended to allow the Company to offer and issue, from time to time, common shares, debt securities, warrants, subscription receipts and units (or any combination thereof) during the 25-month period that a final base shelf prospectus remains effective. The specific terms of any future offering (including, where applicable, the number and price of the securities offered and the use of proceeds) will be set out in one or more prospectus supplements filed in connection with any such offering. The Company has filed the Base Shelf Prospectus to maintain financial flexibility, and there is no certainty that any securities will be offered or sold under the base shelf prospectus within its effective period.","length":776,"tagName":"p"},{"type":"text","content":"This news release does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States absent registration or an applicable exemption. A copy of the Base Shelf Prospectus, and any documents incorporated by reference therein, is available under the Company's profile on SEDAR+.","length":517,"tagName":"p"},{"type":"text","content":"About Onco-Innovations Limited","length":30,"tagName":"p"},{"type":"text","...